PET scan for kidney cancer after treatment
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses a special PET scan to detect if kidney cancer remains or returns after treatment. It may help find cancer that's hard to see on other scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have kidney cancer that was treated and may still be present or has come back
- Or you have a new kidney mass that might be cancer
- You are 18 years or older
- You are able to give your written consent
- You are not pregnant or breastfeeding, and will use contraception if needed
- You don't have severe kidney disease or a known allergy to the study drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new imaging agent called 18F-NY104 to see if it can help doctors see kidney cancer tumors on a PET/CT scan. If you have known or suspected kidney cancer that has spread or come back, this study may help find out if the tracer works for you.
This trial tests a special PET scan that may help doctors see if a complex kidney cyst is cancerous before surgery. It is for people who are already scheduled to have surgery to remove a kidney mass.
This trial tests a new imaging agent that might help doctors see whether a kidney mass is cancer before surgery. It may help guide treatment decisions.
This trial tests a special PET scan to see if it can better find leftover kidney cancer after surgery compared to a standard CT scan. You may qualify if you had kidney cancer surgery within the last 4-16 weeks and are at high risk of the cancer coming back.
This study tests whether a special PET scan (using a radioactive tracer called rubidium-82) can help doctors better understand how aggressive a kidney cancer is before surgery. If you have a medium-sized kidney tumor that looks like clear cell cancer and you are scheduled for surgery, you may be able to join.
This study tests a new type of PET scan that uses a tracer called 68Ga-RCCB6 to see kidney cancer more clearly. It compares this scan to another PET scan (68Ga-PSMA) to help doctors stage the cancer, check treatment response, and detect any return of the disease.
Hear when a new ccRCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.